Schizophrenia
Showing NaN - NaN of 144
Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010; paliperidone palmitate, INVEGA SUSTENNA)
Active, not recruiting
- Schizophrenia
- +11 more
- LY03010; paliperidone palmitate
- INVEGA SUSTENNA
-
Garden Grove, California
- +8 more
Nov 19, 2021
Schizophrenia, Alcohol Use Disorder Trial in Bulgaria, Poland, United States (Samidorphan + olanzapine (ALKS 3831), Placebo +
Completed
- Schizophrenia
- Alcohol Use Disorder
- Samidorphan + olanzapine (ALKS 3831)
- Placebo + olanzapine
-
Little Rock, Arkansas
- +70 more
Sep 14, 2021
Schizophrenia Trial in Bulgaria, Czechia, United States (Samidorphan (Low Dose), Samidorphan (Medium Dose), Samidorphan (High
Completed
- Schizophrenia
- Samidorphan (Low Dose)
- +4 more
-
Little Rock, Arkansas
- +60 more
Sep 10, 2021
Schizophrenia Trial in Worldwide (SEP-363856, Placebo - Cap)
Schizophrenia Trial in Garden Grove, Glendale (LY2140023, Aripiprazole)
Completed
- Schizophrenia
-
Garden Grove, California
- +1 more
Aug 17, 2021
Schizophrenia Trial in Garden Grove (PERSERIS, Risperidone)
Completed
- Schizophrenia
-
Garden Grove, CaliforniaCollaborative Neuroscience Network
Jun 13, 2021
Schizophrenia, Schizoaffective Disorder Trial in Worldwide (ziprasidone)
Completed
- Schizophrenia
- Schizoaffective Disorder
-
Phoenix, Arizona
- +39 more
Mar 1, 2021
Potential Biomarkers in Schizophrenia and Healthy Volunteer
Completed
- Schizophrenia
- Event-Related Potentials (ERP) and Electroencephalogram (EEG) testing with the COGNISION® System
-
Garden Grove, California
- +3 more
Feb 22, 2021
Schizophrenia Trial in Worldwide (BI 425809 dose 1, BI 425809 dose 2, BI 425809 dose 3)
Completed
- Schizophrenia
- BI 425809 dose 1
- +4 more
-
Garden Grove, California
- +80 more
Feb 5, 2021